Lee's Pharmaceutical Taiwan | 李氏大藥廠

Azilsartan Tablets won the “Guangdong Prominent High-tech Products” award

admin — Fri, 13 Sep 2024 07:49:22 +0000

Recently, the Guangdong High-tech Association granted the certificates of “Guangdong Prominent High-tech Products” for 2023. The Azilsartan Tablets, an in-house developed product of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), won the award by virtue of its outstanding innovation capacity, advanced technology, reliable quality and good market prospect.

The post Azilsartan Tablets won the “Guangdong Prominent High-tech Products” award first appeared on Lee's Pharmaceutical Taiwan | 李氏大藥廠.

The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product winning award again

admin — Fri, 05 Jul 2024 07:14:17 +0000

The 2024 China Medical and Health Industry Symbiosis Conference, organized by Menet, a healthcare information platform, was grandly held in Huzhou from 25 to 28 June, 2024. A number of lists were released during the conference, including the “China Pharmaceutical Industry Top 100 Series List” and the “Most Valuable Product in Partnership for Drug Store Chain”.

The post The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product winning award again first appeared on Lee's Pharmaceutical Taiwan | 李氏大藥廠.

The Group’s in-house developed product Adapalene and Clindamycin Hydrochloride Gel was successfully launched

admin — Wed, 12 Jun 2024 07:46:54 +0000

May 30, 2024, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) grandly held the launch ceremony at its Guangzhou Nansha site for its new product Adapalene and Clindamycin Hydrochloride Gel. The Group’s Managing Director, Ms. Wanee Leelalertsuphakun, and staff members of different departments were present at the event to jointly witness the start of a new chapter in acne treatment marked by the product.

The post The Group’s in-house developed product Adapalene and Clindamycin Hydrochloride Gel was successfully launched first appeared on Lee's Pharmaceutical Taiwan | 李氏大藥廠.

The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched

admin — Fri, 24 May 2024 07:47:44 +0000

Recently, the “Symposium on the Progress of Nitric Oxide Inhalation Therapy in Newborns” organized by the Shanghai Caritas Foundation took place at the Guangzhou Southern Airlines Pearl Airport Hotel. During the conference, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) held a launch event for its new rare disease products, Nitric Oxide for Inhalation (INOmax®) and INOmax DSIR Plus Delivery System.

The post The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched first appeared on Lee's Pharmaceutical Taiwan | 李氏大藥廠.

Lee’s Pharmaceutical participated in the 88th PharmChina

admin — Mon, 20 May 2024 07:48:52 +0000

May 15, 2024, the high-profile 88th PharmChina was grandly opened at the Shanghai National Exhibition and Convention Center. As a significant event in the industry, the exhibition attracted 150,000 visitors and brought together nearly 4,000 pharmaceutical companies to showcase their latest products and technological achievements. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) participated in the event.

The post Lee’s Pharmaceutical participated in the 88th PharmChina first appeared on Lee's Pharmaceutical Taiwan | 李氏大藥廠.

Zhaoke-Hefei was honored with the “Safe Enterprise” title in Hefei for the year 2023

admin — Fri, 08 Mar 2024 07:50:07 +0000

Recently, the Hefei Municipal Department of Economy and Information Technology announced the list of “Safe Enterprises” for the year 2023. After several rounds of selection, Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke-Hefei”), a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, HKEx:00950), has been honored with this title.

The post Zhaoke-Hefei was honored with the “Safe Enterprise” title in Hefei for the year 2023 first appeared on Lee's Pharmaceutical Taiwan | 李氏大藥廠.